Android Apple

UroGen Pharma Ltd. (URGN) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$10.82

north_east $0.11 (1.03%)
Day's range
$10.51
Day's range
$10.88

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
10/14/2024 EF Hutton Jason Kolbert $25.00 $12.60   98.41%
06/14/2024 Evercore ISI Stephen Richardson $46.00 $20.26   127.05%
06/14/2024 Oppenheimer Leland Gershell $40.00 $17.50   128.57%
06/14/2024 H.C. Wainwright Raghuram Selvaraju $60.00 $17.50   242.86%
06/14/2024 Goldman Sachs Paul Choi $22.00 $17.50   25.71%
05/14/2024 Oppenheimer Leland Gershell $32.00 $13.07   144.84%
03/15/2024 Oppenheimer Leland Gershell $34.00 $14.46   135.13%
No analyst forecast available for this stock.

UroGen Pharma Ltd. FAQ's

What analysts cover UroGen Pharma Ltd.?

UroGen Pharma Ltd. has been rated by research analysts at EF Hutton, Evercore ISI, Oppenheimer, H.C. Wainwright, Goldman Sachs in the past 90 days.

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.